Radiopharmaceutical Stem Cell Tracking for Neurological Diseases

Abstract EN

Although neurological ailments continue to be some of the main causes of disease burden in the world, current therapies such as pharmacological agents have limited potential in the restoration of neural functions.

Cell therapies, firstly applied to treat different hematological diseases, are now being investigated in preclinical and clinical studies for neurological illnesses.

However, the potential applications and mechanisms for such treatments are still poorly comprehended and are the focus of permanent research.

In this setting, noninvasive in vivo imaging allows better understanding of several aspects of stem cell therapies.

Amongst the various methods available, radioisotope cell labeling has become one of the most promising since it permits tracking of cells after injection by different routes to investigate their biodistribution.

A significant increase in the number of studies utilizing this method has occurred in the last years.

Here, we review the different radiopharmaceuticals, imaging techniques, and findings of the preclinical and clinical reports published up to now.

Moreover, we discuss the limitations and future applications of radioisotope cell labeling in the field of cell transplantation for neurological diseases.